Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Edwin Asturias

Concepts (460)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Guatemala
53
2025
327
4.190
 Why?
Microcephaly
5
2024
98
2.750
 Why?
Zika Virus Infection
6
2024
165
2.690
 Why?
Influenza, Human
9
2025
622
2.510
 Why?
Vaccines
7
2024
406
2.410
 Why?
Rural Population
17
2025
563
2.410
 Why?
Poliovirus Vaccine, Inactivated
6
2018
28
2.150
 Why?
Vaccination
16
2025
1381
2.010
 Why?
Poliomyelitis
8
2018
37
1.920
 Why?
Poliovirus Vaccine, Oral
7
2018
25
1.780
 Why?
Zika Virus
5
2024
128
1.730
 Why?
Infant
44
2025
9465
1.670
 Why?
Dengue
6
2024
80
1.580
 Why?
Viral Vaccines
4
2025
98
1.410
 Why?
Child Development
4
2025
475
1.340
 Why?
Virus Shedding
9
2024
48
1.280
 Why?
Streptococcus pneumoniae
5
2025
169
1.250
 Why?
Pneumonia, Pneumococcal
3
2025
48
1.190
 Why?
Community-Acquired Infections
3
2025
174
1.150
 Why?
Caliciviridae Infections
2
2018
20
1.110
 Why?
Norovirus
2
2018
26
1.110
 Why?
Poliovirus
6
2018
85
1.070
 Why?
Haemophilus Vaccines
5
2016
30
1.040
 Why?
Gastroenteritis
2
2017
69
1.040
 Why?
Child, Preschool
30
2025
11074
1.020
 Why?
Dengue Virus
6
2024
52
1.000
 Why?
Reminder Systems
2
2019
169
0.990
 Why?
Text Messaging
2
2019
157
0.950
 Why?
Growth Disorders
2
2023
86
0.940
 Why?
Health Knowledge, Attitudes, Practice
5
2023
1329
0.920
 Why?
Hepatitis B Vaccines
4
2016
45
0.920
 Why?
Antigens, Bacterial
1
2025
127
0.900
 Why?
Fever
2
2017
306
0.900
 Why?
Humans
99
2025
137585
0.860
 Why?
Immunization Schedule
5
2017
197
0.860
 Why?
Streptococcal Vaccines
1
2023
6
0.850
 Why?
Immunization
4
2023
411
0.810
 Why?
Meningitis, Meningococcal
1
2022
6
0.800
 Why?
Neisseria meningitidis
1
2022
23
0.790
 Why?
Cell Phone
3
2019
76
0.790
 Why?
Meningococcal Infections
1
2022
25
0.790
 Why?
Child
28
2025
21935
0.760
 Why?
Meningococcal Vaccines
1
2022
55
0.760
 Why?
Neurodevelopmental Disorders
1
2024
181
0.740
 Why?
Family Characteristics
5
2025
191
0.720
 Why?
Prospective Studies
17
2025
7604
0.720
 Why?
Streptococcal Infections
1
2023
151
0.720
 Why?
Female
59
2025
73304
0.680
 Why?
Serogroup
5
2025
44
0.680
 Why?
Antibodies, Neutralizing
4
2017
286
0.670
 Why?
Infant, Newborn
16
2025
6079
0.670
 Why?
Virus Diseases
1
2022
212
0.660
 Why?
Pregnancy Complications, Infectious
2
2022
394
0.660
 Why?
Endpoint Determination
1
2020
77
0.660
 Why?
Rural Health Services
2
2019
128
0.650
 Why?
Product Surveillance, Postmarketing
2
2025
63
0.640
 Why?
Diarrhea
5
2023
184
0.630
 Why?
Adverse Drug Reaction Reporting Systems
2
2025
77
0.630
 Why?
Immunity, Humoral
3
2017
116
0.630
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
3
2016
25
0.630
 Why?
Influenza Vaccines
3
2021
539
0.620
 Why?
Contraception
4
2022
161
0.610
 Why?
Adolescent Health
1
2019
39
0.600
 Why?
Immunity, Mucosal
2
2016
97
0.590
 Why?
Arbovirus Infections
1
2018
21
0.590
 Why?
Community Health Services
2
2019
227
0.580
 Why?
Sentinel Surveillance
2
2017
49
0.580
 Why?
Patient Acceptance of Health Care
3
2020
806
0.580
 Why?
Haemophilus influenzae type b
2
2014
12
0.570
 Why?
Male
48
2025
67762
0.570
 Why?
Carrier State
3
2014
67
0.550
 Why?
Urban Health Services
1
2017
63
0.540
 Why?
Immunogenicity, Vaccine
1
2017
30
0.540
 Why?
Multiplex Polymerase Chain Reaction
3
2025
54
0.520
 Why?
Consumer Product Safety
1
2016
33
0.510
 Why?
Community Health Planning
1
2016
44
0.500
 Why?
Neonatal Screening
1
2017
169
0.500
 Why?
Public-Private Sector Partnerships
1
2016
43
0.500
 Why?
Physician Assistants
1
2017
94
0.490
 Why?
Family Planning Services
3
2022
92
0.480
 Why?
Anemia, Hemolytic
1
2015
20
0.480
 Why?
Population Health
1
2016
47
0.480
 Why?
Parents
3
2023
1347
0.470
 Why?
Schools
1
2019
461
0.470
 Why?
Population Surveillance
2
2025
482
0.470
 Why?
Latin America
5
2018
93
0.470
 Why?
Post-Exposure Prophylaxis
1
2014
9
0.460
 Why?
Castleman Disease
1
2014
13
0.450
 Why?
Mobile Applications
1
2017
183
0.450
 Why?
Herpes Zoster
2
2015
316
0.450
 Why?
Exanthema
1
2015
78
0.450
 Why?
Advisory Committees
1
2016
219
0.450
 Why?
Sexual Behavior
1
2019
485
0.450
 Why?
Needs Assessment
2
2016
376
0.440
 Why?
Haemophilus Infections
1
2014
42
0.440
 Why?
Pregnancy
13
2024
6763
0.440
 Why?
Adolescent
23
2025
21513
0.440
 Why?
Brain Diseases
1
2015
141
0.430
 Why?
Bacterial Capsules
2
2014
30
0.420
 Why?
Caregivers
1
2021
877
0.420
 Why?
Adolescent Behavior
1
2019
530
0.420
 Why?
Calcitonin
1
2013
27
0.420
 Why?
Receptors, Interleukin-6
1
2013
43
0.420
 Why?
Health Behavior
1
2019
762
0.410
 Why?
Global Health
1
2016
386
0.400
 Why?
Antibodies, Bacterial
2
2014
146
0.400
 Why?
Protein Precursors
1
2013
134
0.390
 Why?
Bacterial Infections
2
2013
250
0.390
 Why?
Young Adult
17
2025
13209
0.380
 Why?
Drug-Related Side Effects and Adverse Reactions
3
2025
250
0.370
 Why?
Hospitalization
7
2022
2199
0.370
 Why?
Feces
8
2018
484
0.370
 Why?
Adult
30
2025
37929
0.370
 Why?
Intestines
4
2018
357
0.370
 Why?
Chikungunya Fever
2
2025
79
0.360
 Why?
Antibodies, Monoclonal, Humanized
2
2014
804
0.360
 Why?
Diet
1
2019
1278
0.350
 Why?
Intestinal Mucosa
1
2016
623
0.340
 Why?
Antigens, Viral
2
2024
178
0.340
 Why?
Contraceptive Agents
2
2021
66
0.340
 Why?
Pleural Effusion
2
2024
54
0.330
 Why?
Saccharum
3
2020
77
0.320
 Why?
Hepatitis B Antibodies
1
2009
11
0.310
 Why?
Surveys and Questionnaires
5
2021
5778
0.310
 Why?
Nasopharynx
2
2025
76
0.300
 Why?
Dengue Vaccines
2
2018
10
0.290
 Why?
Immunosuppressive Agents
1
2013
890
0.290
 Why?
Delivery, Obstetric
2
2019
144
0.290
 Why?
Agriculture
2
2020
103
0.290
 Why?
Antibodies, Viral
7
2022
625
0.290
 Why?
Malnutrition
1
2009
83
0.280
 Why?
Urban Population
3
2019
479
0.280
 Why?
World Health Organization
3
2017
123
0.280
 Why?
Appointments and Schedules
2
2019
89
0.270
 Why?
RNA, Viral
2
2021
656
0.260
 Why?
Primary Health Care
1
2017
1738
0.260
 Why?
Seroconversion
2
2017
46
0.260
 Why?
Acute Disease
3
2019
1007
0.250
 Why?
Cohort Studies
6
2025
5742
0.250
 Why?
Cross-Sectional Studies
5
2023
5472
0.250
 Why?
Anti-Bacterial Agents
4
2025
1809
0.240
 Why?
Immunization Programs
3
2024
213
0.240
 Why?
Blood Culture
1
2025
23
0.230
 Why?
Glomerular Filtration Rate
2
2020
746
0.230
 Why?
Viruses
2
2023
113
0.230
 Why?
Viral Load
2
2024
466
0.230
 Why?
Anthropometry
2
2022
213
0.220
 Why?
Vaccines, Conjugate
2
2022
65
0.220
 Why?
Head
1
2025
105
0.220
 Why?
Chikungunya virus
1
2025
80
0.220
 Why?
Meningitis, Haemophilus
1
2003
6
0.210
 Why?
Bacteremia
2
2025
214
0.210
 Why?
Postpartum Period
3
2022
340
0.210
 Why?
Culex
1
2023
16
0.210
 Why?
Ritonavir
1
2024
74
0.210
 Why?
Respiratory Syncytial Virus Infections
1
2025
128
0.210
 Why?
Saliva
1
2025
242
0.210
 Why?
Streptococcus pyogenes
1
2023
45
0.200
 Why?
Antimicrobial Stewardship
1
2025
118
0.200
 Why?
Aedes
1
2023
65
0.200
 Why?
Postnatal Care
2
2021
71
0.200
 Why?
Anti-Infective Agents
2
2020
255
0.200
 Why?
Psychometrics
3
2021
720
0.200
 Why?
Incidence
4
2022
2804
0.190
 Why?
Vomiting
1
2023
130
0.190
 Why?
Propensity Score
1
2024
294
0.190
 Why?
Travel
3
2015
130
0.190
 Why?
Seroepidemiologic Studies
2
2022
165
0.190
 Why?
Seasons
2
2025
547
0.190
 Why?
Vital Signs
1
2022
43
0.190
 Why?
Cough
1
2023
122
0.190
 Why?
Vaccines, Attenuated
2
2025
132
0.190
 Why?
Regression Analysis
2
2022
1024
0.190
 Why?
Biomarkers
1
2013
4149
0.190
 Why?
Quality Improvement
5
2022
1178
0.190
 Why?
Meningitis, Bacterial
2
2015
47
0.190
 Why?
Herpesvirus 3, Human
2
2015
332
0.190
 Why?
Risk Factors
10
2025
10388
0.180
 Why?
Polymerase Chain Reaction
1
2024
1062
0.180
 Why?
Escherichia coli Vaccines
2
2013
4
0.180
 Why?
Drug Therapy, Combination
3
2016
1066
0.180
 Why?
Vaccines, Combined
3
2024
48
0.180
 Why?
Cesarean Section
2
2019
184
0.180
 Why?
Health Services Accessibility
2
2020
986
0.180
 Why?
Health Promotion
2
2019
741
0.180
 Why?
Attitude
1
2023
259
0.180
 Why?
Midwifery
1
2022
52
0.170
 Why?
Malaria Vaccines
1
2020
8
0.170
 Why?
Respiratory Tract Infections
1
2025
390
0.170
 Why?
Influenza A Virus, H3N2 Subtype
1
2021
45
0.170
 Why?
Outpatients
1
2024
396
0.170
 Why?
Yellow fever virus
1
2020
4
0.170
 Why?
Birth Intervals
1
2020
23
0.170
 Why?
Immunologic Deficiency Syndromes
2
2015
69
0.170
 Why?
Public Health
3
2025
588
0.170
 Why?
Reproducibility of Results
4
2021
3284
0.170
 Why?
Yellow Fever
1
2020
8
0.170
 Why?
Maternal Health Services
1
2022
98
0.170
 Why?
Molecular Diagnostic Techniques
1
2021
105
0.160
 Why?
Absenteeism
1
2020
49
0.160
 Why?
Cesarean Section, Repeat
1
2019
11
0.160
 Why?
Intensive Care, Neonatal
1
2020
40
0.160
 Why?
Vaccination Refusal
1
2020
70
0.160
 Why?
Emergency Service, Hospital
2
2022
2069
0.160
 Why?
Vaginal Birth after Cesarean
1
2019
25
0.160
 Why?
Agricultural Workers' Diseases
1
2020
31
0.160
 Why?
Drug Discovery
1
2020
142
0.160
 Why?
Language Tests
1
2019
23
0.160
 Why?
Contraception Behavior
1
2020
102
0.160
 Why?
Maternal Age
1
2019
129
0.150
 Why?
Real-Time Polymerase Chain Reaction
1
2020
346
0.150
 Why?
Language Development Disorders
1
2019
41
0.150
 Why?
Motor Skills
1
2020
97
0.150
 Why?
Arboviruses
1
2018
16
0.150
 Why?
Clinical Trials as Topic
1
2023
1050
0.150
 Why?
Thinness
1
2019
91
0.150
 Why?
Puerto Rico
1
2018
53
0.150
 Why?
Entamoeba histolytica
1
2018
7
0.150
 Why?
Farmers
1
2019
64
0.140
 Why?
Pregnancy in Adolescence
1
2019
83
0.140
 Why?
Heat Stress Disorders
1
2019
76
0.140
 Why?
Socioeconomic Factors
2
2025
1289
0.140
 Why?
Treatment Refusal
1
2018
89
0.140
 Why?
Vulnerable Populations
1
2019
163
0.140
 Why?
Mothers
3
2022
754
0.140
 Why?
Child Health
1
2019
154
0.130
 Why?
Sensitivity and Specificity
4
2025
1946
0.130
 Why?
Educational Status
1
2019
470
0.130
 Why?
Occupational Health
2
2018
200
0.130
 Why?
Intensive Care Units, Neonatal
1
2020
257
0.130
 Why?
Neoplasms
2
2016
2671
0.130
 Why?
Diagnostic Tests, Routine
1
2018
110
0.130
 Why?
Poliovirus Vaccines
1
2016
6
0.130
 Why?
Health Surveys
1
2019
514
0.130
 Why?
Colorado
3
2024
4565
0.130
 Why?
Middle Aged
11
2025
33479
0.130
 Why?
Pneumococcal Infections
2
2016
115
0.130
 Why?
Central Nervous System Viral Diseases
1
2018
79
0.130
 Why?
HIV Infections
2
2014
2836
0.130
 Why?
Child Behavior
1
2019
248
0.130
 Why?
Panama
1
2016
13
0.130
 Why?
Myelitis
1
2018
107
0.130
 Why?
Dominican Republic
1
2016
24
0.130
 Why?
Colombia
1
2016
41
0.130
 Why?
Databases, Factual
3
2019
1357
0.130
 Why?
Peru
1
2016
58
0.120
 Why?
Neuromuscular Diseases
1
2018
132
0.120
 Why?
Community Health Nursing
1
2016
61
0.120
 Why?
Measles-Mumps-Rubella Vaccine
1
2016
42
0.120
 Why?
Risk-Taking
1
2019
348
0.120
 Why?
Host-Pathogen Interactions
1
2019
364
0.120
 Why?
Sanitation
1
2016
55
0.120
 Why?
Anemia, Hemolytic, Autoimmune
1
2015
14
0.120
 Why?
Rotavirus Vaccines
1
2016
46
0.120
 Why?
Learning
1
2020
409
0.120
 Why?
Water Supply
1
2016
78
0.120
 Why?
Health Services Needs and Demand
1
2017
273
0.120
 Why?
Chickenpox
1
2016
83
0.120
 Why?
Single-Blind Method
1
2016
282
0.120
 Why?
Analysis of Variance
1
2018
1316
0.120
 Why?
Typhoid Fever
1
2015
10
0.120
 Why?
Patient Preference
1
2017
191
0.120
 Why?
Occupational Exposure
1
2019
341
0.120
 Why?
Health Information Systems
1
2015
17
0.120
 Why?
Enterovirus Infections
1
2018
177
0.120
 Why?
Community Participation
1
2016
131
0.120
 Why?
Data Collection
1
2018
673
0.110
 Why?
Aged, 80 and over
2
2025
7635
0.110
 Why?
Education, Nursing
1
2016
97
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Disease Outbreaks
1
2018
395
0.110
 Why?
Fatal Outcome
1
2015
303
0.110
 Why?
Malaria
1
2015
63
0.110
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2014
86
0.110
 Why?
Overweight
1
2019
558
0.110
 Why?
Biomedical Research
1
2020
692
0.110
 Why?
Vincristine
1
2014
116
0.110
 Why?
Cyclophosphamide
1
2014
247
0.110
 Why?
Severity of Illness Index
2
2020
2828
0.110
 Why?
History, 21st Century
1
2014
213
0.110
 Why?
Mucocutaneous Lymph Node Syndrome
1
2014
91
0.110
 Why?
Enterotoxins
1
2013
88
0.110
 Why?
Rituximab
1
2014
176
0.100
 Why?
Prednisone
1
2014
240
0.100
 Why?
Calcitonin Gene-Related Peptide
1
2013
38
0.100
 Why?
Universities
1
2016
433
0.100
 Why?
Renal Insufficiency, Chronic
1
2020
617
0.100
 Why?
History, 20th Century
1
2014
325
0.100
 Why?
Students
1
2019
622
0.100
 Why?
Bacterial Toxins
1
2013
106
0.100
 Why?
Case-Control Studies
1
2021
3556
0.100
 Why?
Causality
1
2013
126
0.100
 Why?
Education, Medical
1
2016
266
0.100
 Why?
Communicable Diseases
1
2015
159
0.100
 Why?
Health Policy
1
2016
388
0.100
 Why?
United States
7
2025
14841
0.100
 Why?
Doxorubicin
1
2014
362
0.100
 Why?
Lymphocytes
1
2014
397
0.100
 Why?
Delivery of Health Care
1
2019
951
0.100
 Why?
Practice Guidelines as Topic
1
2020
1587
0.090
 Why?
Gene Expression Profiling
1
2019
1774
0.090
 Why?
Lymph Nodes
1
2014
491
0.090
 Why?
Escherichia coli Proteins
1
2013
200
0.090
 Why?
Aged
7
2025
23961
0.090
 Why?
Program Evaluation
1
2016
898
0.090
 Why?
Acute Kidney Injury
1
2019
815
0.090
 Why?
Hypertension
1
2020
1295
0.090
 Why?
Kidney
1
2018
1468
0.080
 Why?
Interleukin-6
1
2014
778
0.080
 Why?
Decision Support Systems, Clinical
1
2013
226
0.080
 Why?
Influenza A Virus, H1N1 Subtype
1
2011
148
0.080
 Why?
Immunization, Secondary
1
2010
87
0.080
 Why?
Clinical Competence
1
2017
1118
0.080
 Why?
Escherichia coli
1
2013
815
0.080
 Why?
Physicians
1
2017
910
0.070
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2007
42
0.070
 Why?
Creatinine
2
2020
499
0.070
 Why?
Penicillins
1
2007
58
0.070
 Why?
Drug Resistance, Multiple, Bacterial
1
2007
78
0.070
 Why?
Time Factors
4
2025
6828
0.070
 Why?
Prevalence
2
2025
2734
0.060
 Why?
Contact Tracing
1
2025
27
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
1692
0.060
 Why?
Cities
2
2016
133
0.060
 Why?
Influenza B virus
1
2025
44
0.060
 Why?
Basic Reproduction Number
1
2025
5
0.060
 Why?
Drug Administration Schedule
1
2007
786
0.060
 Why?
Neuropsychological Tests
2
2020
1023
0.060
 Why?
Mexico
3
2013
225
0.060
 Why?
Respiratory Syncytial Virus, Human
1
2025
74
0.060
 Why?
Sepsis
2
2003
617
0.060
 Why?
Influenza A virus
1
2025
107
0.050
 Why?
Tomography, X-Ray Computed
1
2014
2691
0.050
 Why?
Mosquito Vectors
1
2023
30
0.050
 Why?
Policy Making
1
2024
98
0.050
 Why?
Haemophilus influenzae
1
2003
63
0.050
 Why?
Treatment Outcome
4
2020
10811
0.050
 Why?
China
1
2024
217
0.050
 Why?
Chickens
1
2023
191
0.050
 Why?
Antiviral Agents
2
2024
744
0.050
 Why?
Bayes Theorem
1
2025
405
0.050
 Why?
Developing Countries
2
2016
307
0.050
 Why?
Cross Reactions
1
2022
133
0.050
 Why?
Randomized Controlled Trials as Topic
2
2019
1477
0.050
 Why?
Pandemics
1
2011
1639
0.050
 Why?
Longitudinal Studies
2
2020
2844
0.050
 Why?
Mammals
1
2023
283
0.050
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2024
234
0.050
 Why?
Administration, Cutaneous
2
2013
129
0.040
 Why?
Hospitals
2
2016
691
0.040
 Why?
Paraguay
1
2020
3
0.040
 Why?
Sri Lanka
1
2020
7
0.040
 Why?
Endemic Diseases
1
2020
32
0.040
 Why?
Reagent Kits, Diagnostic
1
2020
42
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2022
852
0.040
 Why?
Translations
1
2020
17
0.040
 Why?
Home Health Nursing
1
2019
12
0.040
 Why?
Hospitals, Pediatric
2
2015
508
0.040
 Why?
Specific Gravity
1
2019
11
0.040
 Why?
Child Language
1
2019
19
0.040
 Why?
Parity
1
2019
126
0.040
 Why?
Prenatal Care
1
2022
294
0.040
 Why?
Translating
1
2019
43
0.040
 Why?
Rural Health
1
2019
80
0.040
 Why?
Electrolytes
1
2019
58
0.040
 Why?
Dehydration
1
2019
51
0.040
 Why?
Parasites
1
2019
50
0.040
 Why?
Reproductive Health
1
2019
90
0.040
 Why?
Culturally Competent Care
1
2019
63
0.040
 Why?
Work Capacity Evaluation
1
2018
11
0.040
 Why?
Infectious Disease Transmission, Vertical
1
2020
184
0.040
 Why?
Bacteria
2
2019
858
0.040
 Why?
Feasibility Studies
1
2022
956
0.040
 Why?
Coinfection
1
2019
137
0.040
 Why?
House Calls
1
2019
138
0.040
 Why?
Chi-Square Distribution
1
2019
530
0.040
 Why?
Education, Medical, Continuing
1
2019
127
0.040
 Why?
Adjuvants, Immunologic
1
2019
226
0.040
 Why?
Licensure
1
2017
13
0.030
 Why?
Pregnancy Outcome
1
2020
416
0.030
 Why?
Retrospective Studies
4
2020
15657
0.030
 Why?
Chromatography, Affinity
1
2017
88
0.030
 Why?
Epitope Mapping
1
2017
62
0.030
 Why?
Choice Behavior
1
2019
170
0.030
 Why?
Francisella
1
1997
2
0.030
 Why?
Paralysis
1
2018
71
0.030
 Why?
Parenteral Nutrition
1
1998
107
0.030
 Why?
Counseling
1
2020
391
0.030
 Why?
Granulomatous Disease, Chronic
1
1997
55
0.030
 Why?
Gastrointestinal Tract
1
2019
195
0.030
 Why?
Sequence Alignment
1
2017
343
0.030
 Why?
Gram-Negative Bacterial Infections
1
1997
46
0.030
 Why?
Women's Health
1
2019
372
0.030
 Why?
Double-Blind Method
2
2013
1993
0.030
 Why?
Enterovirus D, Human
1
2018
85
0.030
 Why?
Acyclovir
1
2016
101
0.030
 Why?
ROC Curve
1
2017
554
0.030
 Why?
Chile
1
2015
24
0.030
 Why?
Cholestasis
1
1998
235
0.030
 Why?
IgG Deficiency
2
2006
7
0.030
 Why?
IgA Deficiency
2
2006
6
0.030
 Why?
Age Distribution
1
2016
392
0.030
 Why?
Sex Distribution
1
2016
375
0.030
 Why?
Infusions, Intravenous
1
2016
413
0.030
 Why?
Residence Characteristics
1
2018
351
0.030
 Why?
Spleen
1
1997
514
0.030
 Why?
Pneumococcal Vaccines
1
2016
142
0.030
 Why?
Healthy Volunteers
1
2015
199
0.030
 Why?
Computational Biology
1
2019
644
0.030
 Why?
Pedigree
1
2015
514
0.030
 Why?
Blood Pressure
1
2021
1786
0.030
 Why?
Maternal-Fetal Exchange
1
2014
165
0.030
 Why?
Amino Acid Sequence
1
2017
2139
0.030
 Why?
Transcriptome
1
2019
971
0.020
 Why?
Europe
1
2013
414
0.020
 Why?
Checklist
1
2013
93
0.020
 Why?
Survival Analysis
1
2015
1325
0.020
 Why?
High-Throughput Nucleotide Sequencing
1
2015
539
0.020
 Why?
Adrenal Cortex Hormones
1
2015
565
0.020
 Why?
Survival Rate
1
2016
1972
0.020
 Why?
Lymphocyte Activation
1
2015
1142
0.020
 Why?
Oncology Service, Hospital
1
2011
16
0.020
 Why?
Oseltamivir
1
2011
12
0.020
 Why?
Comorbidity
1
2016
1622
0.020
 Why?
Nuclear Proteins
1
2015
712
0.020
 Why?
Antibodies, Monoclonal
1
2017
1430
0.020
 Why?
Smoking
1
2018
1627
0.020
 Why?
Drug Delivery Systems
1
2013
365
0.020
 Why?
El Salvador
1
2010
6
0.020
 Why?
Body Mass Index
1
2018
2389
0.020
 Why?
Animals
2
2023
36940
0.020
 Why?
Latex Fixation Tests
1
2008
3
0.020
 Why?
Brain Damage, Chronic
1
2008
18
0.020
 Why?
Leukocytosis
1
2008
30
0.020
 Why?
Coma
1
2008
32
0.020
 Why?
Bacteriological Techniques
1
2008
73
0.020
 Why?
Cerebrospinal Fluid
1
2008
92
0.020
 Why?
DNA-Binding Proteins
1
2015
1502
0.020
 Why?
Cells, Cultured
1
2015
4193
0.020
 Why?
Child Day Care Centers
1
2007
36
0.020
 Why?
Shock
1
2008
98
0.020
 Why?
Follow-Up Studies
1
2016
5131
0.020
 Why?
Risk Assessment
1
2016
3457
0.020
 Why?
Ethiopia
1
2006
41
0.020
 Why?
Postoperative Complications
1
1998
2654
0.020
 Why?
Microbial Sensitivity Tests
1
2007
361
0.020
 Why?
Pakistan
1
2006
76
0.020
 Why?
Algorithms
1
2013
1704
0.020
 Why?
Antineoplastic Agents
1
2016
2129
0.010
 Why?
Agammaglobulinemia
1
2004
34
0.010
 Why?
Common Variable Immunodeficiency
1
2004
29
0.010
 Why?
Brazil
1
2004
167
0.010
 Why?
Ambulatory Care
1
2007
546
0.010
 Why?
Confidence Intervals
1
2004
329
0.010
 Why?
United Kingdom
1
2004
318
0.010
 Why?
Short Bowel Syndrome
1
1998
26
0.010
 Why?
Bilirubin
1
1998
97
0.010
 Why?
Liver Failure
1
1998
94
0.010
 Why?
Water Microbiology
1
1997
85
0.010
 Why?
Abscess
1
1997
75
0.010
 Why?
Asturias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (460) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)